Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CTSU E1609 Principal Investigator: Linette, Gerald
Title: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a- 2b for Resected High-Risk Melanoma
Phase: III Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to compare the effects, good and/or bad, of ipilimumab with interferon alfa-2b on patients and their melanoma to find out which is better.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)